American Well Corp
$ 4.08
0.25%
03 Dec - close price
- Market Cap 66,795,000 USD
- Current Price $ 4.08
- High / Low $ 4.22 / 4.01
- Stock P/E N/A
- Book Value 15.62
- EPS -7.19
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.15 %
- ROE -0.37 %
- 52 Week High 12.95
- 52 Week Low 3.71
About
American Well Corporation (AMWL) is a leading telehealth technology provider based in Boston, focused on enhancing healthcare delivery through its innovative virtual care solutions. The company facilitates real-time connections between patients and a broad network of healthcare providers, significantly improving access to medical services and patient outcomes while driving cost efficiencies. Through strategic partnerships with health plans, employers, and healthcare providers, American Well has established a robust telehealth platform that positions it favorably in the rapidly growing digital health market. As a pioneer in telemedicine, American Well is well-equipped to address the evolving demands of the healthcare landscape.
Analyst Target Price
$8.12
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-29 | 2025-08-05 | 2025-05-01 | 2025-02-12 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-14 | 2023-11-01 | 2023-08-02 | 2023-05-03 | 2023-02-22 |
| Reported EPS | -1.5516 | -1.24 | -1.17 | -1.96 | -2.29 | -3.36 | -0.25 | -0.17 | -0.48 | -0.33 | -0.24 | -0.22 |
| Estimated EPS | -1.46 | -1.74 | -1.88 | -2.55 | -3.11 | -3.98 | -0.19 | -0.2 | -0.21 | -0.22 | -0.21 | -0.25 |
| Surprise | -0.0916 | 0.5 | 0.71 | 0.59 | 0.82 | 0.62 | -0.06 | 0.03 | -0.27 | -0.11 | -0.03 | 0.03 |
| Surprise Percentage | -6.274% | 28.7356% | 37.766% | 23.1373% | 26.3666% | 15.5779% | -31.5789% | 15% | -128.5714% | -50% | -14.2857% | 12% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMWL
2025-10-23 02:02:06
The provided content indicates a "403 Forbidden" error, suggesting that access to the article about American Well Corporation Class stock is restricted. Therefore, no information about the stock's potential worth or investment advice before Fed action is available.
2025-10-23 02:02:06
This article indicates a server error, specifically a 404 "File or directory not found" error. It suggests that the intended content about how American Well Corporation Class stock benefits from digital adoption is currently unavailable or has been moved.
2025-10-23 02:02:06
American Well Corporation Class A (AMWL) reported a decrease in total revenue to $254.4 million for the year, down from $259.0 million, primarily due to reduced visit volume and lower utilization in specialty care. Despite the revenue decline, the company significantly reduced its net loss from $679.2 million to $212.6 million, partly due to the absence of last year's goodwill impairment charge and reductions in operating expenses. AMWL also announced the sale of its telepsychiatry services business to Avel eCare, LLC for $20.7 million, aligning with its strategic focus on the Converge platform and profitability.
2025-10-23 02:02:06
American Well's (AMWL) Q1 2025 results show strong software revenue growth and improved margins, but its future hinges on the critical DHA contract renewal. The DHA contract is Amwell’s largest growth driver, and its renewal is essential for achieving 2026 positive cash flow and sustaining high-margin revenue. The author recommends a HOLD rating on AMWL stock, advising investors to wait for DHA contract clarity and evidence of execution before considering buying.
2025-10-23 02:02:06
Amwell (NYSE: AMWL) has issued 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements. These RSUs follow a four-year vesting schedule, with 25% vesting after one year and the remaining 75% vesting quarterly over three years. The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, adhering to NYSE's Listed Company Manual Rule 303A.08.
2025-10-23 02:02:06
The article reports a 403 Forbidden error, indicating that access to the requested content about American Well Corporation Class stock is denied. This means no information regarding earnings trends or buy signals is available to assess whether the stock is worth buying before potential Federal Reserve action.
